Trimethyl-Octadecyl-Ammonium Chloride
CAS 112-03-8
Trimethyl-Octadecyl-Ammonium Chloride (CAS 112-03-8) is a pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 2100 nM | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Trimethyl-Octadecyl-Ammonium Chloride used for in pharmaceutical contexts?
Trimethyl-Octadecyl-Ammonium Chloride (CAS 112-03-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Trimethyl-Octadecyl-Ammonium Chloride?
No adverse-event association or SIDER side-effect rows are rendered for Trimethyl-Octadecyl-Ammonium Chloride in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Trimethyl-Octadecyl-Ammonium Chloride also used in cosmetics?
No same-CAS cosmetics profile is rendered from the ingredients-table cross-reference for Trimethyl-Octadecyl-Ammonium Chloride.
What clinical phase is Trimethyl-Octadecyl-Ammonium Chloride in?
No phase 1-4 clinical development badge is rendered for Trimethyl-Octadecyl-Ammonium Chloride because the matched compound identifier rows do not contain a max-phase value.